Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Lucira Health, Inc. - Common Stock
(NQ:
LHDX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Lucira Health, Inc. - Common Stock
Lucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale Process
March 28, 2023
Combination Test Also Secures Point-Of-Care Authorization in Australia
From
Lucira Health Inc.
Via
GlobeNewswire
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
March 01, 2023
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its
Via
MarketBeat
Topics
Initial Public Offering
Exposures
COVID-19
Product Safety
Securities Market
Lucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy Filing
February 27, 2023
Test Delivers Lab-Quality Performance with Results in 30 Minutes or Less – The First At-Home Test to Ever Include Flu
From
Lucira Health Inc.
Via
GlobeNewswire
Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
February 22, 2023
No debtor-in-possession financing required as the Company intends to fund operations and the sale process with available cash on hand.
From
Lucira Health Inc.
Via
GlobeNewswire
Lucira Health Launches Lucira Connect, a Free Test-to-Treat Telehealth Service for Covid-19 or Flu in Canada
January 04, 2023
From
Lucira Health Inc.
Via
GlobeNewswire
Lucira Health Submits EUA for Over-The-Counter (OTC) Use of its COVID-19 & Flu Test
January 03, 2023
From
Lucira Health Inc.
Via
GlobeNewswire
Lucira Health Announces FDA Authorization of Combination COVID-19 & Flu Test at Point-of-Care
November 22, 2022
PCR-Quality Accuracy with Results in 30 Minutes or Less, Just in Time for Flu Season
From
Lucira Health Inc.
Via
GlobeNewswire
Lucira Health Announces National Launch of Lucira Connect Test-to-Treat Service
November 17, 2022
From
Lucira Health Inc.
Via
GlobeNewswire
Lucira Health Announces Third Quarter 2022 Results and Provides Business Updates
November 14, 2022
From
Lucira Health Inc.
Via
GlobeNewswire
Lucira Health to Announce Third Quarter 2022 Financial Results
November 01, 2022
From
Lucira Health Inc.
Via
GlobeNewswire
Lucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays
September 29, 2022
Study Reveals Lucira’s Testing Assays Offer a 98% Accuracy Rate in Detecting Both Sexually Transmitted Infections
From
Lucira Health Inc.
Via
GlobeNewswire
INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Lucira Health, Inc. and Encourages Investors with Losses to Contact the Firm
December 05, 2021
LOS ANGELES, CA - (NewMediaWire) - December 5, 2021 - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lucira...
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Lucira Health, Inc. and Encourages Investors with Losses to Contact the Firm
November 04, 2021
From
The Schall Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lucira Health, Inc. and Encourages Investors with Losses to Contact the Firm
November 01, 2021
From
The Schall Law Firm
Via
Business Wire
LHDX EQUITY ALERT: Rosen Law Firm Encourages Lucira Health, Inc. Investors with Losses to Inquire About Class Action Investigation – LHDX
November 01, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
LUCIRA™ HEALTH Hires Ghazi Kashmolah as Chief Quality Officer and EVP Regulatory Affairs
August 23, 2021
From
Lucira Health, Inc.
Via
Business Wire
LUCIRA™ HEALTH Hires Chief Revenue Officer Kevin Collins
May 28, 2021
From
Lucira Health, Inc.
Via
Business Wire
LUCIRA™ CHECK IT COVID-19 Self-Test Now Available on Amazon
May 12, 2021
From
Lucira Health, Inc.
Via
Business Wire
Lucira Health Celebrates Grand Opening of New Jabil Manufacturing Plant, Increasing Production of LUCIRA CHECK IT™ COVID-19 Self-Test
April 29, 2021
From
Lucira Health, Inc.
Via
Business Wire
Health Canada Authorizes First COVID-19 Test For Self-Testing At Home
April 26, 2021
From
Lucira Health, Inc.
Via
Business Wire
For the First Time Ever, NBA Fans Can Test Themselves for COVID-19 Before Attending a Live Game. Testing Program Debuts in San Francisco Bay Area this Friday with LUCIRA™ Check It COVID-19 At-Home Test
April 22, 2021
From
Lucira Health, Inc.
Via
Business Wire
FDA Authorizes First Single-Use, PCR Quality Over the Counter (OTC) LUCIRA CHECK IT™ COVID-19 At-Home Test. Available Now.
April 12, 2021
From
Lucira Health, Inc.
Via
Business Wire
LUCIRA COVID-19 Test Kit Identifies Viral Variants
April 09, 2021
From
Lucira Health, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.